Fisetin inhibits osteoclastogenesis through prevention of RANKL-induced ROS production by Nrf2-mediated up-regulation of phase II antioxidant enzymes. (Q50751253)
Jump to navigation
Jump to search
scientific article published on 29 March 2013
| Language | Label | Description | Also known as |
|---|---|---|---|
| English | Fisetin inhibits osteoclastogenesis through prevention of RANKL-induced ROS production by Nrf2-mediated up-regulation of phase II antioxidant enzymes. |
scientific article published on 29 March 2013 |
Statements
Fisetin inhibits osteoclastogenesis through prevention of RANKL-induced ROS production by Nrf2-mediated up-regulation of phase II antioxidant enzymes. (English)
1 reference
Eiko Sakai
1 reference
Megumi Shimada-Sugawara
1 reference
Yu Yamaguchi
1 reference
Hiroshi Sakamoto
1 reference
Reiko Fumimoto
1 reference
Yutaka Fukuma
1 reference
Kazuhisa Nishishita
1 reference
Kuniaki Okamoto
1 reference
Takayuki Tsukuba
1 reference
29 March 2013
1 reference
121
1 reference
4
1 reference
288-298
1 reference